Showing results (1171-1180 of 6,769) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|October 9, 2007
Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patientsGregory A Nichols, Carol E KoroClinical Therapeutics|October 9, 2007
Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failureAnn D Bagchi, Dominick Esposito, Myoung Kim, et al.Clinical Therapeutics|November 1, 1991
Detection and assessment of insomniaC A Czeisler, G S RichardsonClinical Therapeutics|November 1, 1991
Acute and short-term effects of nitrendipine and diltiazem at rest and during exercise in hypertensive patientsG Gambini, C Valori, L Bianchi, et al.Clinical Therapeutics|November 1, 1991
Metabolic effects of nitrendipineG Paolisso, E Aceto, G Cennamo, et al.Clinical Therapeutics|November 1, 1991
Treatment of presumed bacterial pneumonia in ambulatory childrenE Calderon, R Gatica, G Echániz, et al.Clinical Therapeutics|November 1, 1991
Efficacy and tolerability of enalapril (20 mg)/hydrochlorothiazide (12.5 mg) combination therapy in essential hypertensionE Strocchi, A Bossini, G Ranieri, et al.Clinical Therapeutics|November 24, 2007
Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertensionSang-Hyun Kim, Young-Dae Kim, Do-Sun Lim, et al.Clinical Therapeutics|November 24, 2007
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosisBrenda Breuer, Marco Pappagallo, Helena Knotkova, et al.Clinical Therapeutics|November 24, 2007
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosisSteven R Schwid, Hillel S PanitchPageof 677